Immune (Idiopathic) Thrombocytopenic Purpura (ITP) News

This RSS feed URL is deprecated


This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

Nurse award recipient announced - Journal Gazette and Times-Courier



Journal Gazette and Times-Courier
 
Nurse award recipient announced 
Journal Gazette and Times-Courier
During the award presentation, McDevitt received a certificate, a DAISY Award pin and a unique, hand-carved serpentine stone sculpture from Zimbabwe, entitled, ?A Healer's Touch.? The DAISY Award was established in memory of J. Patrick Barnes, who died ...

 


Clinical Practice Updates in the Management Of Immune Thrombocytopenia - P&T Community



Clinical Practice Updates in the Management Of Immune Thrombocytopenia 
P&T Community
Immune thrombocytopenia (ITP), previously called idiopathic thrombocytopenia purpura, is an autoimmune disorder characterized by a severe reduction in peripheral blood platelet count. In healthy individuals, normal platelet count ranges from 150?450 ...

 


Positive opinion to extend use of romiplostim in paediatric patients - Hospital Healthcare Europe



Positive opinion to extend use of romiplostim in paediatric patients 
Hospital Healthcare Europe
Amgen has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion to expand the current indication for NplateŽ (romiplostim) to include the treatment of chronic ...

 


Role of Polymorphisms in Idiopathic Thrombocytopenic Purpura: A Review - Oncology Nurse Advisor



Oncology Nurse Advisor
 
Role of Polymorphisms in Idiopathic Thrombocytopenic Purpura: A Review 
Oncology Nurse Advisor
The main cause of ITP remains unidentified; however, researchers suggest that certain polymorphisms in respective genes are potential factors for ITP. Immune thrombocytopenic purpura (ITP) is an autoimmune disease in which the body increases antibody ...

 


Novartis drug RevoladeŽ shows long-term disease control for ... - GlobeNewswire (press release)



Novartis drug RevoladeŽ shows long-term disease control for ... 
GlobeNewswire (press release)
Basel, October 18, 2017 - Novartis today announced long-term study results supporting the positive safety and efficacy of Revolade (eltrombopag) in adults with chronic/persistent (enrolling patients that were 6 or more months from diagnosis) immune ...

and more » 


Intravenous Immunoglobulin (IVIG) Market to become US$ 14.92 ... - satPRnews (press release)



Intravenous Immunoglobulin (IVIG) Market to become US$ 14.92 ... 
satPRnews (press release)
Transparency Market Research estimates that the global intravenous immunoglobulin (IVIG) market, which was valued at US$7.23 bn in 2015, is projected to expand at a CAGR of 8.5% from 2016 to 2024 and reach US$14.92 bn in 2024. In terms of end users ...

and more » 


Amgen Receives Positive CHMP Opinion To Expand Use Of Nplate ... - PR Newswire (press release)



Amgen Receives Positive CHMP Opinion To Expand Use Of Nplate ... 
PR Newswire (press release)
THOUSAND OAKS, Calif., Nov. 10, 2017 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion to expand the current ...

and more » 


FDA Approves Gammaplex 10% for Primary immunodeficiency and ... - Rare Disease Report



Rare Disease Report
 
FDA Approves Gammaplex 10% for Primary immunodeficiency and ... 
Rare Disease Report
The FDA has approved Gammaplex 10% (immune globulin intravenous [human], 10% liquid) for the treatment of primary immunodeficiency (PI) and chronic immune thrombocytopenic purpura (ITP) in adults. In 2013, the FDA approved Gammaplex 5% and the newer ...

and more » 


Combination of Western Care With Chinese Medicine Shows Potential in ITP - Oncology Nurse Advisor



Oncology Nurse Advisor
 
Combination of Western Care With Chinese Medicine Shows Potential in ITP 
Oncology Nurse Advisor
The pathogenesis of idiopathic thrombocytopenic purpura (ITP) may be associated with Th17 helper T cells; therefore, Western-style care supplemented by traditional Chinese medicine may lead to optimal outcomes in patients with ITP, according to a study ...

 


Rituximab vs Splenectomy: Response Similar in Immune Thrombocytopenic Purpura - Oncology Nurse Advisor



Oncology Nurse Advisor
 
Rituximab vs Splenectomy: Response Similar in Immune Thrombocytopenic Purpura 
Oncology Nurse Advisor
Patients with steroid-refractory immune thrombocytopenic purpura (ITP) may not have significantly different responses to rituximab or splenectomy as second-line therapy, according to a study published in The International Journal of Hematology. ITP is ...